Navigation Links
Webinar: WCRI and Brandeis University Discuss Opioids
Date:12/26/2013

Cambridge, MA (PRWEB) December 26, 2013

The Workers Compensation Research Institute (WCRI) announced today that it will host an hour-long webinar panel on Thursday, January 16, 2014 at 1pm ET (12pm CT, 11am MT, and 10am PT) to share lessons on how states can control the misuse and abuse of opioids.

“As policymakers and other stakeholders look for ways to further control opioid misuse and abuse, WCRI is happy to provide this webinar panel that will provide lessons for states on this very important issue,” said Dr. Richard Victor, WCRI’s executive director.

The first panelist, WCRI’s Dr. Vennela Thumula, will share findings from WCRI’s study, Impact of Banning Physician Dispensing of Opioids in Florida. This study examines changes in the prescribing of opioids to newly injured workers before and after the implementation of legislation (House Bill 7095) in Florida, which was effective July 1, 2011.

The second panelist, Dr. Peter Kreiner of Brandeis University, will provide initial findings from a longitudinal, multi-state database of prescription drug monitoring program (PDMP) data. The findings include (1) a comparison of selected measures of patient, prescriber, and dispenser behavior across several states; and (2) effects of the new PDMP in Florida (operational on September 1, 2011) on measures of risky patient, prescriber, and pharmacy behavior.

Questions addressed:

  •     Did the Florida ban reduce the overall prescribing of opioids to injured workers?
  •     Does physician dispensing lead to over utilization/unnecessary utilization of opioids?
  •     How can PDMP data be used for public health surveillance purposes?
  •     Did the implementation of Florida’s PDMP have an immediate effect on prescribing and dispensing behaviors? Has the effect persisted?

Attendance is limited to 100 people and all attendees receive a free copy of the slides. Webinars are $39 for WCRI Members; $79 for Non-Members; and no charge for members of the press, legislators as well as their staff, and state public officials who make policy decisions impacting their state’s workers’ compensation system.

Click on the following link to register: http://www.wcrinet.org/1.16.14_webinar_reg.html.

The Cambridge-based WCRI is an independent, non-partisan research center that is recognized as a leader in providing high-quality, objective information about public policy issues involving workers' compensation systems.

ABOUT WCRI:

WCRI is an independent, not-for-profit research organization based in Cambridge, MA. Organized in late 1983, WCRI does not take positions on the issues it researches; rather, it provides information obtained through studies and data collection efforts, which conform to recognized scientific methods. Objectivity is further ensured through rigorous, unbiased peer review procedures. WCRI’s diverse membership includes employers; insurers; governmental entities; managed care companies; health care providers; insurance regulators; state labor organizations; and state administrative agencies in the U.S., Canada, Australia, and New Zealand. For more information, visit: http://www.wcrinet.org.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11442537.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Webinar: How to Use Online Reviews to Get More Leads
2. Webinar: Comparing Payments for Hospital and Professional Services for Injured Workers across States and the Impact of Reforms
3. Join Merrill DataSite's Webinar: Best Practices for Strategic Growth - Where to Invest in the Maturing U.S. Economy
4. Register to Join the Merrill DataSite's Webinar: Avoiding the Post-Merger Blues: How to Reduce the Risk of Post-deal Disputes
5. Webinar: Comparing Prices in Group Health vs. Workers' Compensation
6. Live Webinar: Bridging the Gap Between Network and Endpoint Security with Next-Generation Ecosystem Featuring Verdasys and FireEye
7. Molecular Imaging, Inc. Announces New Webinar: Advancing Discovery and Development of Biologics Through Non-Invasive Biodistribution Imaging
8. June 27 Webinar: Health Insurance Marketing Experts to Discuss Marketing Strategies Ahead of October Open-Enrollment Date
9. June 25 Webinar: Gorman Health Group Senior VP of Finance Will Discuss How Medicare ACOs Can Transition to Medicare Advantage
10. Register to Join Merrill DataSite's Webinar: M&A Regulatory and Tax Changes and Their Impact on Deal Structure
11. Join Merrill DataSite's Webinar: PE Success Stories of the Top Dealmakers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... ... Hamlin Dental Group and Dr. Hamid Reza, dentist in North Hollywood ... of February, patients who visit Hamlin Dental Group will receive a ticket for a ... the Cheesecake Factory. , Tickets are available for routine dental visits and other ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an approved content provider for the National Institute for Health and Care ... social care-related organizations in the National Health Service (NHS) to search, order and ...
(Date:2/23/2017)... ... ... Dr. David Mahon leads Siena Dental, a comprehensive dental practice located at ... Top Patient Rated Henderson Dentist by Find Local Doctors earlier this year. ... dentists who have earned high ratings and superior patient reviews from multiple credible sources. ...
(Date:2/23/2017)... ... February 23, 2017 , ... ERT, a global data ... that Premier Research, a leading clinical development service provider, has selected ERT’s Trial ... complex, due in part to an array of circumstances including the use of ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... the pre-eminent publication and community for those in the fight against cancer, has ... important in their success. HRA will release top-line findings in a webinar, ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 23, 2017 Tillotts Pharma is ... Berlin office was opened in January ... The portfolio includes Entocort ® for the treatment ... of ulcerative colitis, and VistaPrep ® for bowel ... specialty pharmaceutical company focused on the treatment of gastrointestinal ...
(Date:2/23/2017)... MabVax Therapeutics Holdings, Inc . ... announces that it has received notice from the ... initiation a Phase I clinical trial with MVT-1075 ... ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s novel fully ... the phase I clinical trial in patients with ...
(Date:2/23/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) ( ... and dermatology biopharmaceutical company, today announced that it has ... as special advisers to the Company,s Board of ... board on financial and corporate strategy. Provectus ... of up to $2.5 million from Eric Wachter ...
Breaking Medicine Technology: